Mytrex Health Technologies, Inc. (TPEX:4431)

TPEX:4431 Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	275.02	218.66	486.53	471.21	735.29
Short-Term Investments	2.5	22.09	-	-	-
Trading Asset Securities	-	-	-	-	19.51
Cash & Short-Term Investments	277.52	240.75	486.53	471.21	754.8
Cash Growth	15.28%	-50.52%	3.25%	-37.57%	402.50%
Accounts Receivable	139.14	164.67	110.21	54.91	124.44
Other Receivables	52.19	41.18	53.43	-	2.14
Receivables	191.33	205.85	163.64	54.91	126.57
Inventory	200.96	203.22	184.58	54.9	96.86
Other Current Assets	21.82	22.11	22.67	19.06	21.5
Total Current Assets	691.64	671.93	857.42	600.08	999.73
Property, Plant & Equipment	129.04	241.14	285.37	253.19	284.75
Long-Term Investments	111.06	101.28	102.35	61.42	22.15
Goodwill	12.99	12.99	12.99	-	-
Other Intangible Assets	70.82	71.61	76.1	1.16	1.51
Long-Term Accounts Receivable	8.51	8.66	-	-	-
Long-Term Deferred Tax Assets	6.09	4.89	3.32	4.52	3.19
Other Long-Term Assets	115.54	145.7	150.51	33.74	14.48
Total Assets	1,146	1,258	1,488	954.12	1,326
Accounts Payable	208.37	228.4	204.44	5.74	20.97
Accrued Expenses	32.47	38.43	50.88	30.14	56.28
Short-Term Debt	61.09	57.47	13.25	-	109.04
Current Portion of Long-Term Debt	4.45	1.99	-	-	-
Current Portion of Leases	45.99	70.52	51.08	10.89	8.34
Current Income Taxes Payable	-	0.82	5.19	8.01	87.81
Current Unearned Revenue	1.28	2.61	1.55	0.96	3.39
Other Current Liabilities	51.51	41.52	31.03	19.2	23.48
Total Current Liabilities	405.15	441.75	357.42	74.94	309.31
Long-Term Debt	1.69	4.31	-	-	-
Long-Term Leases	111.22	116.39	144.5	43.61	42.09
Long-Term Deferred Tax Liabilities	10.62	11	11.43	-	-
Other Long-Term Liabilities	7.69	7.27	7.01	-	-
Total Liabilities	536.37	580.72	520.36	118.55	351.39
Common Stock	365.36	365.36	365.36	365.36	243.57
Additional Paid-In Capital	291.46	291.46	288.25	288.25	291.15
Retained Earnings	-52.4	32.97	89.12	179.94	437.34
Comprehensive Income & Other	-4.24	-14.94	-12.94	0.16	0.42
Total Common Equity	600.17	674.84	729.79	833.71	972.48
Minority Interest	9.13	2.63	237.9	1.86	1.95
Shareholders' Equity	609.31	677.47	967.7	835.57	974.43
Total Liabilities & Equity	1,146	1,258	1,488	954.12	1,326
Total Debt	224.44	250.67	208.83	54.51	159.47
Net Cash (Debt)	53.09	-9.93	277.7	416.7	595.33
Net Cash Growth	-	-	-33.36%	-30.00%	398.60%
Net Cash Per Share	1.45	-0.27	7.60	11.41	18.10
Filing Date Shares Outstanding	36.54	36.54	36.54	36.54	36.54
Total Common Shares Outstanding	36.54	36.54	36.54	36.54	36.54
Working Capital	286.49	230.18	500	525.14	690.43
Book Value Per Share	16.43	18.47	19.97	22.82	26.62
Tangible Book Value	516.37	590.25	640.71	832.55	970.97
Tangible Book Value Per Share	14.13	16.16	17.54	22.79	26.58
Land	-	13.9	13.9	-	-
Buildings	-	15.15	15.15	-	-
Machinery	400	395.33	393.57	370.97	331.03
Construction In Progress	-	-	11.61	-	16.59
Leasehold Improvements	67.32	82.88	72.41	47.61	42.36

Source: S&P Global Market Intelligence. Standard template. Financial Sources.